Literature DB >> 11073756

Gynecologic infections in human immunodeficiency virus-infected women.

J D Sobel1.   

Abstract

The maturation of the acquired immunodeficiency syndrome epidemic has now claimed more than 12 million women worldwide, the majority in undeveloped countries where human immunodeficiency virus (HIV) and sexually transmitted infections coexist and interact synergistically. Among HIV-infected women, there is excessive morbidity due to sexually transmitted diseases (STDs) and gynecologic disorders. This review summarizes the expanding understanding of vaginal flora, vaginitis, cervicitis, pelvic inflammatory disease, and genital ulcer disease in HIV-infected women. In addition to the altered clinical course, complications, and management difficulties of STDs, some gynecologic infections may influence HIV transmission as well as the vertical transmission of HIV to the newborn. Finally, severe immunodeficiency allows unusual opportunistic pathogens to invade the upper and lower genital tract. Control and prevention of gynecologic infections in HIV-positive and HIV-negative women are key components to preventing further HIV transmission.

Entities:  

Mesh:

Year:  2000        PMID: 11073756     DOI: 10.1086/317436

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.

Authors:  Nonhlanhla N Nkwanyana; Pamela P Gumbi; Lindi Roberts; Lynette Denny; Willem Hanekom; Andreia Soares; Bruce Allan; Anna-Lise Williamson; David Coetzee; Abraham J Olivier; Wendy A Burgers; Jo-Ann Passmore
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

2.  Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women.

Authors:  Gregory T Spear; M Reza Zariffard; Mardge H Cohen; Beverly E Sha
Journal:  J Reprod Immunol       Date:  2008-02-19       Impact factor: 4.054

Review 3.  Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment.

Authors:  Markus Ruhnke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Mechanisms Involved in the Association between Periodontitis and Complications in Pregnancy.

Authors:  Marcela Yang Hui Zi; Priscila Larcher Longo; Bruno Bueno-Silva; Marcia Pinto Alves Mayer
Journal:  Front Public Health       Date:  2015-01-29

Review 5.  Lights and Shadows about the Effectiveness of IVF in HIV Infected Women: A Systematic Review.

Authors:  Catarina Marques; Cristina Guerreiro; Sérgio Reis Soares
Journal:  Infect Dis Obstet Gynecol       Date:  2015-12-08

Review 6.  Beyond the Pap Smear: Gender-responsive HIV Care for Women.

Authors:  Jaimie P Meyer; Julie A Womack; Britton Gibson
Journal:  Yale J Biol Med       Date:  2016-06-27

7.  CD57 expression by T cells in the female genital tract of HIV-zx1 infected women.

Authors:  Lenine J Liebenberg; Adebayo Lawrence Adedeji; Darren P Martin; Pam P Gumbi; Lynette Denny; Jo-Ann S Passmore
Journal:  Clin Immunol       Date:  2010-01-25       Impact factor: 3.969

8.  Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada.

Authors:  Yimeng Zhang; Shari Margolese; Mark H Yudin; Janet M Raboud; Christina Diong; Trevor A Hart; Heather M Shapiro; Cliff Librach; Matt Gysler; Mona R Loutfy
Journal:  ISRN Obstet Gynecol       Date:  2012-08-16

9.  Intractable chronic vulval ulceration presenting as immune reconstitution inflammatory syndrome in a treatment-failure patient: a case observation.

Authors:  Christine Katusiime; Ponsiano Ocama; Andrew Kambugu
Journal:  Case Rep Obstet Gynecol       Date:  2011-09-22

10.  Bacterial vaginosis and human immunodeficiency virus infection.

Authors:  Gregory T Spear; Elizabeth St John; M Reza Zariffard
Journal:  AIDS Res Ther       Date:  2007-10-22       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.